摘要
哮喘是一种常见的慢性气道炎症性疾病,其特征是继发于气道狭窄、气道壁增厚和黏液增加的可逆性气流受限。目前,哮喘被认为是一种复杂的异质性疾病,其具体发病机制尚未明确。参与哮喘发病机制的免疫细胞多种多样,包括T细胞、嗜酸性粒细胞、中性粒细胞等。其中T细胞由于分类及功能不断更新,其对于哮喘的作用也逐渐受到关注。因此,该综述旨在总结不同T细胞亚群的免疫学特征及其在哮喘发病机制中的作用,并综述了某些T细胞亚群在重症哮喘发病机制中的新发现,从而为哮喘免疫学方面的发病机制及临床诊断、治疗、预后的研究提供启发及帮助。
Asthma is a common chronic airway inflammatory disease,which is characterized by airway stenosis,airway wall thickening and increased mucus secretion followed by reversible airflow restriction.At present,asthma is considered to be a complex and heterogeneous disease,and its pathogenesis remains elusive.There are diverse immune cells involved in the formation of asthma,including T lymphocytes,eosinophils,neutrophils,etc.Due to the continuous renewal of classification and function of T lymphocytes subsets,their role in asthma has attracted more attention.Here,this review aims to summarize the immunological characteristics and roles of different T cell subsets in asthma,and highlight the new findings of T cell subsets in the pathogenesis of severe asthma,leading to provide inspiration and help for the study of the immunology pathogenesis,clinical diagnosis,treatment and prognosis in asthma.
作者
王晓倩(综述)
韩晓
张晓波
王立波(审校)
Wang Xiaoqian;Han Xiao;Zhang Xiaobo;Wang Libo(Department of Respiration,Children′s Hospital of Fudan University,Shanghai 201102,China)
出处
《国际儿科学杂志》
2022年第8期510-514,共5页
International Journal of Pediatrics
基金
科技部科技创新2030"新一代人工智能"重大项目(2021ZD0113501)
上海市"科技创新行动计划"自然科学基金(20ZR1408300)。